Fig. 8

Analysis of OTUD7B, TRAF3 and NIK in tissue samples from NSCLC patients. a Representative images of immunohistochemistry (IHC) for OTUD7B, TRAF3 and NIK in cancer tissues from 146 clinical NSCLC patients (× 200). b Correlation analysis among OTUD7B, TRAF3 and NIK expression in human NSCLC specimens (n = 146). c, d The percentage of patients with high or low OTUD7B, TRAF3 and NIK expression in different groups divided by lymphatic invasion and TNM stage. e Kaplan-Meier survival curve of OTUD7B, TRAF3 and NIK proteins in NSCLC patients. Marks on the graph lines represent censored samples. The P-value refers to two-sided log-rank tests